PCV14 AN APPRAISAL OF REAL-WORLD EVIDENCE (RWE) IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOACS)
Abstract
Authors
S. Deitelzweig A. Cichewicz M. DiFusco A. Kang C. Russ K. Snook E. Bergrath A. Earley J.C. Cappelleri